Porcine pancreatic islet cultured with porcine sertoli cells for xenotransplantation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 戴伯塞尔有限公司
- Publication Date
- 2006-06-21
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the use of porcine pancreatic islet cells for treating diabetes. More particularly but not exclusively, the present invention relates to the use of porcine pancreatic islet cells together with Sertoli cells for treating diabetes by xenotransplantation. Background technique
[0002] Background and rationale of porcine islet cell xenotransplantation
[0003] Type 1 (insulin-dependent) diabetes mellitus is a common endocrine disorder that causes considerable morbidity and mortality and has serious economic implications for individual patients and healthcare systems. Although life-saving, treatment with insulin often does not provide sufficient control of blood glucose to prevent life-shortening complications of the disease, prompting extensive research on better ways to achieve and maintain normoglycemia . Among the newer therapeutic strategies proposed, transplantation of pancreatic beta islet cells obtained from human beings ...